Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has been granted approval for its generic version of Pharmacia & Upjohn's Dostinex tablets to treat hyperprolactinemic disorders.
Subscribe to our email newsletter
Teva said shipment of the cabergoline tablets, which have been cleared for 0.5mg strength, will begin immediately.
Total annual sales of this product in the US, including brand and generic sales, are approximately $74 million, based on IMS sales data.
Hyperprolactinemia is the presence of abnormally high levels of the hormone prolactin in the blood, and can cause infertility.